Dysbiosis-associated bile acids slam the brakes on immune checkpoint therapy
Cancer Cell · 2026
DOI: 10.1016/j.ccell.2026.06.013 ↗Kurz gefasst
Kommentar in der Zeitschrift Cancer Cell, 2026. Verfasst von Chi Chun Wong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Digestive Disease and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Healt…. Hauptthemen laut MEDLINE: Dysbiosis, Bile Acids and Salts, Immune Checkpoint Inhibitors, Neoplasms. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Antibiotics compromise the efficacy of immune checkpoint inhibition (ICI) therapy in cancer, but the underlying mechanism remains unclear. In this issue of Cancer Cell, Mallard de La Varende et al. identify dysbiosis-associated tauro-conjugated bile acids as drivers of ICI non-response and γ-glutamyl transferase (γGT) as a predictive biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Digestive Disease and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
- Institute of Digestive Disease and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.…
Zitieren
APA
Wong, C. C., & Yu, J. (2026). Dysbiosis-associated bile acids slam the brakes on immune checkpoint therapy. Cancer Cell. https://doi.org/10.1016/j.ccell.2026.06.013
Vancouver
Wong CC, Yu J. Dysbiosis-associated bile acids slam the brakes on immune checkpoint therapy. Cancer Cell. 2026. doi:10.1016/j.ccell.2026.06.013
BibTeX
@article{Wong2026,
author = {Wong, Chi Chun and Yu, Jun},
title = {Dysbiosis-associated bile acids slam the brakes on immune checkpoint therapy},
journal = {Cancer Cell},
year = {2026},
doi = {10.1016/j.ccell.2026.06.013}
}
EUVIMED